Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways.
about
The Nrf2/HO-1 Axis in Cancer Cell Growth and ChemoresistanceChemoprevention of Breast Cancer by Dietary PolyphenolsThe Anti-Cancer Effect of Polyphenols against Breast Cancer and Cancer Stem Cells: Molecular MechanismsEffects of resveratrol on drug- and carcinogen-metabolizing enzymes, implications for cancer prevention.Differential regulation of estrogen receptors α and β by 4-(E)-{(4-hydroxyphenylimino)-methylbenzene,1,2-diol}, a novel resveratrol analog.New considerations on hormetic response against oxidative stress.microRNA-93 promotes cell proliferation via targeting of PTEN in Osteosarcoma cells.4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, 1 a novel resveratrol analog, differentially regulates estrogen receptors α and β in breast cancer cells.Tamoxifen synergizes with 4-(E)-{(4-hydroxyphenylimino)-methylbenzene, 1,2-diol} and 4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, novel azaresveratrol analogs, in inhibiting the proliferation of breast cancer cells.Resveratrol fuels HER2 and ERα-positive breast cancer behaving as proteasome inhibitor.Breast cancer chemoprevention by dietary natural phenolic compounds: specific epigenetic related molecular targets.Dietary polyphenols and chromatin remodeling.Nrf2: a potential therapeutic target for naturally occurring anticancer drugs?Role of dietary bioactive natural products in estrogen receptor-positive breast cancer.Multiple regulations of Keap1/Nrf2 system by dietary phytochemicals.Resveratrol as an anti-cancer agent: A review.Raf/ERK/Nrf2 signaling pathway and MMP-7 expression involvement in the trigonelline-mediated inhibition of hepatocarcinoma cell migration.Cancer Chemoprevention by Phytochemicals: Nature's Healing Touch.Defining the momiome: Promiscuous information transfer by mobile mitochondria and the mitochondrial genome.Synthesis of Resveratrol Derivatives and In Vitro Screening for Potential Cancer Chemopreventive Activities.4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol} (TIMBD) suppresses HIV1-gp120 mediated production of IL6 and IL8 but not CCL5.Sulforaphane-induced apoptosis involves the type 1 IP3 receptor.3,6-Dihydroxyflavone regulates microRNA-34a through DNA methylation.Differential gene regulation and tumor inhibitory activities of alpha-, delta- and gamma-tocopherols in estrogen-mediated mammary carcinogenesis.Antioxidant activities of novel resveratrol analogs in breast cancer.Extracellular superoxide dismutase and its role in cancer.The Roles of 4β-Hydroxywithanolide E from Physalis peruviana on the Nrf2-Anti-Oxidant System and the Cell Cycle in Breast Cancer Cells.Chemopreventive effects of atractylenolide II on mammary tumorigenesis via activating Nrf2-ARE pathway.Rat Models of 17beta-Estradiol-Induced Mammary Cancer Reveal Novel Insights into Breast Cancer Etiology and Prevention.Nrf2 as molecular target for polyphenols: A novel therapeutic strategy in diabetic retinopathy.Inducers of Senescence, Toxic Compounds, and Senolytics: The Multiple Faces of Nrf2-Activating Phytochemicals in Cancer Adjuvant Therapy.The influence of diet on anti-cancer immune responsiveness.Design and development of Nrf2 modulators for cancer chemoprevention and therapy: a reviewSynergistic Activity of Colistin in Combination With Resveratrol Against Colistin-Resistant Gram-Negative Pathogens
P2860
Q26772298-DC132166-4621-42B9-99D6-A7A71EEA0BE0Q26773449-0726D748-073F-4E1F-93C0-BC92DB358E4BQ28066752-3224637D-314E-4096-B509-85E6745BE90AQ33771427-8EBB4175-F940-4713-9290-9E540D4EF9D2Q34332592-45606806-BB82-4D11-B014-01BE6E175260Q35333384-53735C68-08F6-4586-A2CB-F291B1279A3FQ35914705-0C44B34E-C00D-476B-8C7F-C5EF60C46E09Q35955076-29C749A8-ABDE-4C75-A5CB-C12FB9482463Q37588360-0E6E883E-C20C-4945-AC58-9171D5D33039Q37715501-84E0CFF3-575F-4857-8F48-80E248144AB5Q38266097-00A0B2D2-9AFC-4A79-907E-F2FF46520148Q38584317-71A80354-3DFC-40A9-AB4E-E125011A1349Q38694717-D50218B4-BD88-40B1-91B8-1461B88530AAQ38789308-8AE865BD-8294-4A3D-A455-B115BD95ED51Q38927510-18529FF1-0495-4614-BBB3-718EFF9F437EQ39045911-E87466C0-B7E1-437E-84D4-DDCDFF19A496Q39135443-29A61BAC-A8C2-4080-B80E-30FE903858ADQ39168795-73ED6DA0-CDF4-4EF6-B416-E180435D1DD2Q39305244-4F7FDD31-76FD-49D7-9510-037E2C736D4FQ39782976-9F445232-B2D1-4019-9469-9D8C8721DC80Q40081983-7586997C-AB93-4D54-8A95-3282DF5EF684Q40620916-C1F8933C-A473-4DDE-AD9E-DEBDF735EA3FQ41613271-CD3F1AB1-D5B6-4A9E-A861-5FE134411CD4Q42777954-B99ADB2F-7F2D-4813-AC67-5F29D435DD90Q46299051-DC2366BC-058E-4B20-BDB5-FD06DFF0CE1AQ46316155-D6A020AC-9B17-497F-A91F-8526C2014440Q46558958-F4535117-3EB1-4B74-B19B-40043F06FDA8Q47105785-3D151B2D-B537-4A7D-9FFD-82A1CF2DCD3CQ49662743-F89431BB-C98A-4BE4-AF46-2A15986ADCFFQ50874501-25EEC8BA-C507-4B06-B3A3-BB84413FB63EQ52331716-2E16313A-FF08-4AAD-B7E8-1BC850A387AEQ53700576-3B54DB45-8457-4F46-9639-A5BA1FF68FE8Q57069735-DF82DEB5-6EE7-46EE-A674-0C91FADF64FAQ58797117-43B60D38-60C9-43C8-BCA6-C04FB109BB9D
P2860
Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Resveratrol inhibits estrogen- ...... -mediated protective pathways.
@ast
Resveratrol inhibits estrogen- ...... -mediated protective pathways.
@en
Resveratrol inhibits estrogen- ...... -mediated protective pathways.
@nl
type
label
Resveratrol inhibits estrogen- ...... -mediated protective pathways.
@ast
Resveratrol inhibits estrogen- ...... -mediated protective pathways.
@en
Resveratrol inhibits estrogen- ...... -mediated protective pathways.
@nl
prefLabel
Resveratrol inhibits estrogen- ...... -mediated protective pathways.
@ast
Resveratrol inhibits estrogen- ...... -mediated protective pathways.
@en
Resveratrol inhibits estrogen- ...... -mediated protective pathways.
@nl
P2093
P2860
P356
P1433
P1476
Resveratrol inhibits estrogen- ...... -mediated protective pathways.
@en
P2093
Amruta Ronghe
Anwesha Chatterjee
Bhupendra Singh
Daniel C Dim
Hari K Bhat
Nimee K Bhat
Rivka Shoulson
P2860
P304
P356
10.1093/CARCIN/BGU120
P407
P577
2014-06-03T00:00:00Z